PHGUF
Price
$1.50
Change
+$0.13 (+9.49%)
Updated
Sep 5 closing price
Capitalization
1.02B
SGMO
Price
$0.66
Change
+$0.03 (+4.76%)
Updated
Sep 26 closing price
Capitalization
200.34M
33 days until earnings call
Interact to see
Advertisement

PHGUF vs SGMO

Header iconPHGUF vs SGMO Comparison
Open Charts PHGUF vs SGMOBanner chart's image
Pharming Group
Price$1.50
Change+$0.13 (+9.49%)
Volume$2.13K
Capitalization1.02B
Sangamo Therapeutics
Price$0.66
Change+$0.03 (+4.76%)
Volume$7.08M
Capitalization200.34M
PHGUF vs SGMO Comparison Chart in %
Loading...
PHGUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHGUF vs. SGMO commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHGUF is a Hold and SGMO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (PHGUF: $1.50 vs. SGMO: $0.66)
Brand notoriety: PHGUF and SGMO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHGUF: 89% vs. SGMO: 117%
Market capitalization -- PHGUF: $1.02B vs. SGMO: $200.34M
PHGUF [@Biotechnology] is valued at $1.02B. SGMO’s [@Biotechnology] market capitalization is $200.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHGUF’s FA Score shows that 1 FA rating(s) are green whileSGMO’s FA Score has 0 green FA rating(s).

  • PHGUF’s FA Score: 1 green, 4 red.
  • SGMO’s FA Score: 0 green, 5 red.
According to our system of comparison, PHGUF is a better buy in the long-term than SGMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHGUF’s TA Score shows that 2 TA indicator(s) are bullish while SGMO’s TA Score has 5 bullish TA indicator(s).

  • PHGUF’s TA Score: 2 bullish, 2 bearish.
  • SGMO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SGMO is a better buy in the short-term than PHGUF.

Price Growth

PHGUF (@Biotechnology) experienced а 0.00% price change this week, while SGMO (@Biotechnology) price change was +21.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

SGMO is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHGUF($1.02B) has a higher market cap than SGMO($200M). PHGUF YTD gains are higher at: 52.827 vs. SGMO (-34.902). PHGUF has higher annual earnings (EBITDA): 29.5M vs. SGMO (-54.76M). PHGUF has more cash in the bank: 126M vs. SGMO (38.3M). SGMO has less debt than PHGUF: SGMO (23.5M) vs PHGUF (128M). PHGUF has higher revenues than SGMO: PHGUF (340M) vs SGMO (81.7M).
PHGUFSGMOPHGUF / SGMO
Capitalization1.02B200M512%
EBITDA29.5M-54.76M-54%
Gain YTD52.827-34.902-151%
P/E RatioN/AN/A-
Revenue340M81.7M416%
Total Cash126M38.3M329%
Total Debt128M23.5M545%
FUNDAMENTALS RATINGS
PHGUF vs SGMO: Fundamental Ratings
PHGUF
SGMO
OUTLOOK RATING
1..100
4614
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
93100
PRICE GROWTH RATING
1..100
3864
P/E GROWTH RATING
1..100
11100
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGMO's Valuation (58) in the Biotechnology industry is in the same range as PHGUF (75) in the null industry. This means that SGMO’s stock grew similarly to PHGUF’s over the last 12 months.

PHGUF's Profit vs Risk Rating (83) in the null industry is in the same range as SGMO (100) in the Biotechnology industry. This means that PHGUF’s stock grew similarly to SGMO’s over the last 12 months.

PHGUF's SMR Rating (93) in the null industry is in the same range as SGMO (100) in the Biotechnology industry. This means that PHGUF’s stock grew similarly to SGMO’s over the last 12 months.

PHGUF's Price Growth Rating (38) in the null industry is in the same range as SGMO (64) in the Biotechnology industry. This means that PHGUF’s stock grew similarly to SGMO’s over the last 12 months.

PHGUF's P/E Growth Rating (11) in the null industry is significantly better than the same rating for SGMO (100) in the Biotechnology industry. This means that PHGUF’s stock grew significantly faster than SGMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHGUFSGMO
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
38%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
42%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
41%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
42%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PHGUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFDZX24.050.25
+1.05%
Applied Finance Explorer Institutional
BRULX17.100.17
+1.00%
MFS Blended Research Value Equity R3
UIGRX44.080.22
+0.50%
Victory Growth Institutional
TRIRX78.420.32
+0.41%
Nuveen Large Cap Gr Idx Retire
BFIUX18.040.05
+0.26%
Baron FinTech R6

PHGUF and

Correlation & Price change

A.I.dvisor tells us that PHGUF and DRUG have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHGUF and DRUG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHGUF
1D Price
Change %
PHGUF100%
N/A
DRUG - PHGUF
28%
Poorly correlated
+0.71%
ADXN - PHGUF
25%
Poorly correlated
-1.05%
SGMO - PHGUF
25%
Poorly correlated
+4.86%
XFOR - PHGUF
25%
Poorly correlated
+2.37%
CGTX - PHGUF
22%
Poorly correlated
+5.56%
More

SGMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with XENE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMO
1D Price
Change %
SGMO100%
+4.86%
XENE - SGMO
37%
Loosely correlated
+4.00%
XNCR - SGMO
36%
Loosely correlated
+12.00%
VRDN - SGMO
36%
Loosely correlated
+5.82%
ZBIO - SGMO
33%
Loosely correlated
+7.89%
AMLX - SGMO
33%
Loosely correlated
+5.07%
More